The application procedure and requirements for NMPA (National Medical Products Administration) certification of medical devices in China involve several steps and specific documentation. Here’s a detailed outline of the process:
Application Procedure:
Classification Determination:
- Classify your Device: Determine the classification of your medical device according to the Chinese Medical Device Classification Catalog. This classification will determine the regulatory pathway and specific requirements for certification.
Prepare Technical Documentation:
- Compile Technical File: Prepare a comprehensive technical file that includes:
- Device description and specifications
- Design drawings and diagrams
- Risk analysis according to ISO 14971
- Clinical evaluation reports (if applicable)
- Biocompatibility testing reports according to ISO 10993
- Electrical safety and electromagnetic compatibility (EMC) testing reports
- Quality management system documentation (ISO 13485 compliance)
- Labeling and Instructions for Use (IFU) in Chinese
- Device master record (DMR) containing all necessary documents for device manufacture
- Ensure all documentation is complete, accurate, and compliant with NMPA regulations.
Testing and Evaluation:
- Conduct Testing: Perform testing and evaluation to demonstrate compliance with Chinese regulatory standards for safety, performance, and quality.
- Ensure that all testing is conducted in accredited laboratories and complies with relevant Chinese standards.
Regulatory Submission:
- Submit Application: Submit the application for NMPA certification through the China NMPA Online Registration System (CIRS).
- Complete all required forms and provide detailed information about the device, manufacturing process, and technical documentation.
- Pay applicable fees related to the certification process.
Technical Review:
- Review Process: NMPA will conduct a technical review of the submitted documentation and test reports.
- Evaluate compliance with Chinese regulations and standards.
- Address any queries or requests for additional information from NMPA during the review process.
Inspection (if applicable):
- On-site Inspection: Depending on the risk classification of the device, NMPA may conduct an on-site inspection of the manufacturing facilities.
- Ensure that the facilities and processes meet regulatory requirements and demonstrate adherence to quality management practices.
Approval Decision:
- Receive Certification: Upon successful completion of the technical review and any necessary inspections, NMPA will issue a decision on the application.
- If approved, a NMPA registration certificate will be issued, allowing the device to be marketed and sold in China.
Requirements:
- Quality Management System: Maintain a quality management system that complies with ISO 13485 or an equivalent standard.
- Clinical Data (if applicable): Provide clinical data to demonstrate the safety and efficacy of the device, especially for higher-risk classifications.
- Labeling and Instructions for Use: Ensure that device labeling and IFU are in compliance with NMPA regulations, including Chinese language requirements.
- Post-Market Surveillance: Implement post-market surveillance activities to monitor device performance and report adverse events as required by NMPA.
- Authorized Representative (AR): For foreign manufacturers, appoint an Authorized Representative in China who takes responsibility for regulatory compliance.
Navigating the NMPA certification process requires thorough preparation, compliance with regulatory standards, and often involves working closely with regulatory experts or consultants familiar with Chinese medical device regulations. This ensures a smoother certification process and facilitates timely market entry for your medical device in China.
Contact Us:
Whatsapp or Wechat:+86 15816864648;email address:hito.lin@grzan.cn